ConductScience.org, home

Paper37795644

Randomized Clinical Outcome Trials in Hypertension.

Mancia G and 1 other. Hypertension, 2024. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Randomized Clinical Outcome Trials in Hypertension. Papers, record 37795644. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37795644

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Randomized Clinical Outcome Trials in Hypertension.
PubMed
Journal
Hypertension
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
1.44, provisional
iCite
Revised in PubMed
2026-06-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mancia GGiuseppehttps://orcid.org/0000-0003-0942-3176
2Kjeldsen SESverre Ehttps://orcid.org/0000-0003-2389-0272

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
Cardiovascular DiseasesMajor topic
Humans
Antihypertensive Agents
Blood Pressure

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129967041Does Intensive Glucose Control Cancel Out Benefits of Systolic Blood Pressure Target <120 mm Hg in Patients With Diabetes Mellitus Participating in ACCORD?Hypertension2018https://conductscience.org/library/papers/29967041PubMed
229372279Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach.Diabetologia2018https://conductscience.org/library/papers/29372279PubMed
328858984Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials.J Hypertens2017https://conductscience.org/library/papers/28858984PubMed
426414968Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.Lancet2015https://conductscience.org/library/papers/26414968PubMed
532507038Antihypertensive Treatment in Elderly Frail Patients: Evidence From a Large Italian Database.Hypertension2020https://conductscience.org/library/papers/32507038PubMed
636240838
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial.
Lancet2022https://conductscience.org/library/papers/36240838PubMed
737156253Evidence in favour of ambulatory blood pressure grows but gaps in knowledge remain.Lancet2023https://conductscience.org/library/papers/37156253PubMed
811130406INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.Lancet2000https://conductscience.org/library/papers/11130406PubMed
94862069Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.JAMA1967https://conductscience.org/library/papers/4862069PubMed
1025162203Physician (investigator) inertia in apparent treatment-resistant hypertension - insights from large randomized clinical trials. Lennart Hansson Memorial Lecture.Blood Press2015https://conductscience.org/library/papers/25162203PubMed
1116537662Feasibility of treating prehypertension with an angiotensin-receptor blocker.N Engl J Med2006https://conductscience.org/library/papers/16537662PubMed
1210826567Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment.J Hypertens2000https://conductscience.org/library/papers/10826567PubMed
131969567Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.Lancet1990https://conductscience.org/library/papers/1969567PubMed
1437909131Target blood pressure in isolated systolic hypertension: a meta-analysis of randomized outcome trials.J Hypertens2023https://conductscience.org/library/papers/37909131PubMed
1526551272A Randomized Trial of Intensive versus Standard Blood-Pressure Control.N Engl J Med2015https://conductscience.org/library/papers/26551272PubMed
1627195814Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.JAMA2016https://conductscience.org/library/papers/27195814PubMed
1737395100Effect of antihypertensive treatment in isolated systolic hypertension (ISH) - systematic review and meta-analysis of randomised controlled trials.Blood Press2023https://conductscience.org/library/papers/37395100PubMed
1834232677Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective.Hypertension2021https://conductscience.org/library/papers/34232677PubMed
194914579Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.JAMA1970https://conductscience.org/library/papers/4914579PubMed
2036427519Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes.Lancet Diabetes Endocrinol2022https://conductscience.org/library/papers/36427519PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42453630Real-World Effectiveness and Safety of Ramipril/Indapamide Combination Therapy in Essential Hypertension: A Retrospective Study on UK Primary Care Records.Int J Hypertens2026https://conductscience.org/library/papers/42453630PubMed
42439476Pharmacist-Led Ambulatory Blood Pressure Monitoring in Community Pharmacy: An Operational Feasibility Case Series.Turk J Pharm Sci2026https://conductscience.org/library/papers/42439476PubMed
41892319Estrogen, Epigenetics, and Cardiometabolic Health: Mechanisms and Therapeutic Strategies in Postmenopausal Women.Cells2026https://conductscience.org/library/papers/41892319PubMed
41837912Trends and Predictors of Premature Termination of Cardiovascular Trials: A Systematic Review.JACC Adv2026https://conductscience.org/library/papers/41837912PubMed
41361568Empowering citizens as frontline screeners: a framework with blended learning for cardiovascular risk assessment.Sci Rep2025https://conductscience.org/library/papers/41361568PubMed
40397037Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive Patients.Am J Hypertens2025https://conductscience.org/library/papers/40397037PubMed
39613355[Cardiovascular preventive recommendations. PAPPS 2024 thematic updates].Aten Primaria2024https://conductscience.org/library/papers/39613355PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37795644

GET https://conductscience.org/api/papers/v1/37795644/authors